Cited by 192Iron Metabolism and DisordersErythropoietin and Anemia TreatmentHormonal and reproductive studies

Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells

Open access
Guo, Wen, Bachman, Eric, Li, Michelle, Roy, Cindy N., Blusztajn, Jerzy, Wong, Siu, Chan, Stephen Y., Serra, Carlo +5 more·2013·Aging Cell

Abstract

Summary: Testosterone administration increases hemoglobin levels and has been used to treat anemia of chronic disease. Erythrocytosis is the most frequent adverse event associated with testosterone therapy of hypogonadal men, especially older men. However, the mechanisms by which testosterone increases hemoglobin remain unknown. Testosterone administration in male and female mice was associated with a greater increase in hemoglobin and hematocrit, reticulocyte count, reticulocyte hemoglobin concentration, and serum iron and transferrin saturation than placebo. Testosterone downregulated hepatic hepcidin m RNA expression, upregulated renal erythropoietin m RNA expression, and increased erythropoietin levels. Testosterone‐induced suppression of hepcidin expression was independent of its effects on erythropoietin or hypoxia‐sensing mechanisms. Transgenic mice with liver‐specific constitutive hepcidin over‐expression failed to exhibit the expected increase in hemoglobin in response to testosterone administration. Testosterone upregulated splenic ferroportin expression and reduced iron retention in spleen. After intravenous administration of transferrin‐bound 58 Fe, the amount of 58 Fe incorporated into red blood cells was significantly greater in testosterone‐treated mice than in placebo‐treated mice. Serum from testosterone‐treated mice stimulated hemoglobin synthesis in K 562 erythroleukemia cells more than that from vehicle‐treated mice. Testosterone administration promoted the association of androgen receptor ( AR ) with S mad1 and S mad4 to reduce their binding to bone morphogenetic protein ( BMP )‐response elements in hepcidin promoter in the liver. Ectopic expression of AR in hepatocytes suppressed hepcidin transcription; this effect was blocked dose‐dependently by AR antagonist flutamide. Testosterone did not affect hepcidin m RNA stability. In conclusion, testosterone inhibits hepcidin transcription through its interaction with BMP / S mad signaling. Testosterone administration is associated with increased iron incorporation into red blood cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/acel.12052

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Guo, W., Bachman, E., Li, M., Roy, C. N., Blusztajn, J., Wong, S., Chan, S. Y., Serra, C., Jasuja, R., Travison, T. G., Muckenthaler, M. U., Nemeth, E., & Bhasin, S.
Affiliations
  • Boston University (US)
  • Johns Hopkins University (US)
  • Woods Hole Oceanographic Institution (US)
  • Brigham and Women's Hospital (US)
  • Heidelberg University (DE)
  • University of California, Los Angeles (US)
Corresponding author
  • Guo, Wen
  • Bhasin, Shalender
Venue
Aging Cell
Publisher
Wiley
Published
2013-02-28
Volume
12
Issue
2
Pages
280-291
ISSN
  • 1474-9718 (ISSN-L)
  • 1474-9726
OpenAlex
W2012598190
Cited by
192
References
38
Citations by year
2026: 9 · 2025: 19 · 2024: 3 · 2023: 13 · 2022: 16 · 2021: 6 · 2020: 22 · 2019: 14 · 2018: 11 · 2017: 23 · 2016: 15 · 2015: 16 · 2014: 16 · 2013: 9
FWCI
13.38
Type
journal article
Language
en
Open access
Locations
  • Aging Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Centre National de la Recherche Scientifique
  • National Institutes of Health (5p30ag031679-15)
  • National Institute on Aging (U01AG014369, R21AG037859, R01AG037193, P30-AG031679, 1UO1AG14369)
  • National Heart, Lung, and Blood Institute (K08HL096834)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082722, R01DK056690)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
testosterone, hepcidin, erythropoiesis, erythrocytosis, iron incorporation, erythropoietin, BMP/Smad signaling, androgen receptor, Smad1, SMAD4, iron retention, anemia of chronic disease, hypogonadism, hemoglobin synthesis, flutamide
MeSH terms
Animals, Erythrocytes, Erythropoietin, Female, Gene Expression Regulation, Hemoglobins, Humans, Iron, Liver, Male, Mice, Transgenic, Receptors, Androgen, Spleen, Testosterone, Transcription, Genetic, Transferrin, Signal Transduction, Bone Morphogenetic Proteins, K562 Cells, Hepatocytes, Antimicrobial Cationic Peptides, Mice, Smad Proteins, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review